Clinical Trials Directory

Trials / Completed

CompletedNCT03070821

Therapy of Alzheimer's Disease With Neurofeedback

Neurofeedback and Follow-up With Real-time fMRI to Investigate Cognitive Function in Patients of Mild Cognitive Impairment (MCI) or Alzheimer's Disease (AD)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University Hospital, Aachen · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Accepted

Summary

The project aims to investigate in patients of Alzheimer's disease in a prodromal state (early state of the disease) compared to healthy subjects whether neurofeedback training with functional MRI (fMRI) can improve cognitive ability. It is of interest if voluntary modulation of brain activation with real-time (rt) fMRI as a novel method affects cognitive ability, as well as functional and structural measures of the brain. Over the course of the study subjects will learn a real-world footpath. During neurofeedback training subjects are then asked to recall this footpath while simultaneously trying to modulate their own brain activation based on feedback. Feedback is given about the parahippocampal gyrus - a region of the brain associated with episodic and visuo-spatial memory, which is known to be affected early by Alzheimer's disease pathology. Before and after the training cognitive ability is assessed using neuropsychological tests mainly measuring numerous domains of memory. The investigators hypothesise that the training leads to an improvement of the trained cognitive domain, but also induces changes in brain structure and function.

Conditions

Interventions

TypeNameDescription
OTHERrtfMRI neurofeedback trainingInformation about the state of brain activation was given to subjects. That information was visualised as a thermometer bar. Subjects tried to modulate that activation while performing a mental imagery task.
DEVICE3T MRIA 3T Siemens MRI scanner was used to implement rtfMRI neurofeedback training.

Timeline

Start date
2013-01-30
Primary completion
2016-06-30
Completion
2016-06-30
First posted
2017-03-06
Last updated
2017-03-06

Source: ClinicalTrials.gov record NCT03070821. Inclusion in this directory is not an endorsement.